nodes	percent_of_prediction	percent_of_DWPC	metapath
Sumatriptan—SLCO1A2—Spironolactone—dilated cardiomyopathy	0.419	0.634	CbGbCtD
Sumatriptan—ABCB1—Lisinopril—dilated cardiomyopathy	0.129	0.195	CbGbCtD
Sumatriptan—ABCB1—Spironolactone—dilated cardiomyopathy	0.113	0.171	CbGbCtD
Sumatriptan—Breast cancer—Spironolactone—dilated cardiomyopathy	0.00914	0.0364	CcSEcCtD
Sumatriptan—Unspecified visual loss—Lisinopril—dilated cardiomyopathy	0.00623	0.0248	CcSEcCtD
Sumatriptan—Polydipsia—Furosemide—dilated cardiomyopathy	0.00585	0.0233	CcSEcCtD
Sumatriptan—Instillation site pain—Furosemide—dilated cardiomyopathy	0.00556	0.0221	CcSEcCtD
Sumatriptan—Tetany—Furosemide—dilated cardiomyopathy	0.00556	0.0221	CcSEcCtD
Sumatriptan—Infarction—Lisinopril—dilated cardiomyopathy	0.0049	0.0195	CcSEcCtD
Sumatriptan—Application site pain—Furosemide—dilated cardiomyopathy	0.00412	0.0164	CcSEcCtD
Sumatriptan—Vasculitis—Spironolactone—dilated cardiomyopathy	0.00342	0.0136	CcSEcCtD
Sumatriptan—Dysaesthesia—Lisinopril—dilated cardiomyopathy	0.00315	0.0125	CcSEcCtD
Sumatriptan—Eruption—Furosemide—dilated cardiomyopathy	0.00295	0.0117	CcSEcCtD
Sumatriptan—Cerebral ischaemia—Lisinopril—dilated cardiomyopathy	0.00282	0.0112	CcSEcCtD
Sumatriptan—Transient ischaemic attack—Lisinopril—dilated cardiomyopathy	0.0027	0.0107	CcSEcCtD
Sumatriptan—Renal failure acute—Spironolactone—dilated cardiomyopathy	0.00262	0.0104	CcSEcCtD
Sumatriptan—Thrombosis—Furosemide—dilated cardiomyopathy	0.00256	0.0102	CcSEcCtD
Sumatriptan—Apathy—Furosemide—dilated cardiomyopathy	0.00254	0.0101	CcSEcCtD
Sumatriptan—Blister—Furosemide—dilated cardiomyopathy	0.00252	0.01	CcSEcCtD
Sumatriptan—Flat affect—Furosemide—dilated cardiomyopathy	0.00252	0.01	CcSEcCtD
Sumatriptan—Blindness—Lisinopril—dilated cardiomyopathy	0.00246	0.00978	CcSEcCtD
Sumatriptan—Sleep disturbance—Lisinopril—dilated cardiomyopathy	0.00243	0.00966	CcSEcCtD
Sumatriptan—Nephrolithiasis—Furosemide—dilated cardiomyopathy	0.00226	0.00898	CcSEcCtD
Sumatriptan—Injection site pain—Furosemide—dilated cardiomyopathy	0.00222	0.00884	CcSEcCtD
Sumatriptan—Cramp muscle—Spironolactone—dilated cardiomyopathy	0.00218	0.00867	CcSEcCtD
Sumatriptan—Gastritis—Spironolactone—dilated cardiomyopathy	0.00214	0.00852	CcSEcCtD
Sumatriptan—Hearing impaired—Furosemide—dilated cardiomyopathy	0.00191	0.00758	CcSEcCtD
Sumatriptan—Throat sore—Lisinopril—dilated cardiomyopathy	0.00189	0.00751	CcSEcCtD
Sumatriptan—Oropharyngeal discomfort—Lisinopril—dilated cardiomyopathy	0.00187	0.00745	CcSEcCtD
Sumatriptan—Drowsiness—Spironolactone—dilated cardiomyopathy	0.00186	0.00742	CcSEcCtD
Sumatriptan—Vasculitis—Furosemide—dilated cardiomyopathy	0.00186	0.00739	CcSEcCtD
Sumatriptan—Ventricular fibrillation—Lisinopril—dilated cardiomyopathy	0.00178	0.00707	CcSEcCtD
Sumatriptan—Memory impairment—Lisinopril—dilated cardiomyopathy	0.00173	0.0069	CcSEcCtD
Sumatriptan—Bladder pain—Furosemide—dilated cardiomyopathy	0.00164	0.00652	CcSEcCtD
Sumatriptan—Lightheadedness—Furosemide—dilated cardiomyopathy	0.00162	0.00646	CcSEcCtD
Sumatriptan—Chest discomfort—Lisinopril—dilated cardiomyopathy	0.00154	0.00612	CcSEcCtD
Sumatriptan—Thrombophlebitis—Furosemide—dilated cardiomyopathy	0.00152	0.00605	CcSEcCtD
Sumatriptan—Ventricular extrasystoles—Lisinopril—dilated cardiomyopathy	0.00151	0.00599	CcSEcCtD
Sumatriptan—Viral infection—Lisinopril—dilated cardiomyopathy	0.00151	0.00599	CcSEcCtD
Sumatriptan—Photosensitivity—Furosemide—dilated cardiomyopathy	0.0015	0.00597	CcSEcCtD
Sumatriptan—Oropharyngeal pain—Lisinopril—dilated cardiomyopathy	0.0015	0.00595	CcSEcCtD
Sumatriptan—Swelling—Furosemide—dilated cardiomyopathy	0.00149	0.00594	CcSEcCtD
Sumatriptan—Deafness—Furosemide—dilated cardiomyopathy	0.00147	0.00586	CcSEcCtD
Sumatriptan—Haemolytic anaemia—Furosemide—dilated cardiomyopathy	0.00146	0.0058	CcSEcCtD
Sumatriptan—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.0014	0.00557	CcSEcCtD
Sumatriptan—Vasculitis—Lisinopril—dilated cardiomyopathy	0.00139	0.00555	CcSEcCtD
Sumatriptan—Thirst—Furosemide—dilated cardiomyopathy	0.00138	0.0055	CcSEcCtD
Sumatriptan—Dermatitis bullous—Furosemide—dilated cardiomyopathy	0.00138	0.00548	CcSEcCtD
Sumatriptan—Neck pain—Lisinopril—dilated cardiomyopathy	0.00138	0.00548	CcSEcCtD
Sumatriptan—Musculoskeletal pain—Lisinopril—dilated cardiomyopathy	0.00138	0.00548	CcSEcCtD
Sumatriptan—Pulmonary embolism—Lisinopril—dilated cardiomyopathy	0.00136	0.00541	CcSEcCtD
Sumatriptan—Ventricular tachycardia—Lisinopril—dilated cardiomyopathy	0.00136	0.00541	CcSEcCtD
Sumatriptan—Anaphylactoid reaction—Furosemide—dilated cardiomyopathy	0.00136	0.00541	CcSEcCtD
Sumatriptan—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00135	0.00538	CcSEcCtD
Sumatriptan—Cystitis noninfective—Lisinopril—dilated cardiomyopathy	0.00133	0.00529	CcSEcCtD
Sumatriptan—Salivary hypersecretion—Lisinopril—dilated cardiomyopathy	0.00132	0.00526	CcSEcCtD
Sumatriptan—Malaise—Spironolactone—dilated cardiomyopathy	0.00131	0.00523	CcSEcCtD
Sumatriptan—Cystitis—Lisinopril—dilated cardiomyopathy	0.00131	0.00523	CcSEcCtD
Sumatriptan—Fluid retention—Lisinopril—dilated cardiomyopathy	0.00129	0.00514	CcSEcCtD
Sumatriptan—Photophobia—Lisinopril—dilated cardiomyopathy	0.00128	0.00508	CcSEcCtD
Sumatriptan—Bladder pain—Lisinopril—dilated cardiomyopathy	0.00123	0.0049	CcSEcCtD
Sumatriptan—Discomfort—Spironolactone—dilated cardiomyopathy	0.00123	0.00488	CcSEcCtD
Sumatriptan—Dehydration—Furosemide—dilated cardiomyopathy	0.00122	0.00487	CcSEcCtD
Sumatriptan—Lightheadedness—Lisinopril—dilated cardiomyopathy	0.00122	0.00484	CcSEcCtD
Sumatriptan—Confusional state—Spironolactone—dilated cardiomyopathy	0.0012	0.00477	CcSEcCtD
Sumatriptan—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00119	0.00473	CcSEcCtD
Sumatriptan—Cramp muscle—Furosemide—dilated cardiomyopathy	0.00119	0.00472	CcSEcCtD
Sumatriptan—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00116	0.00463	CcSEcCtD
Sumatriptan—Abdominal distension—Furosemide—dilated cardiomyopathy	0.00115	0.00456	CcSEcCtD
Sumatriptan—Sleep disorder—Lisinopril—dilated cardiomyopathy	0.00114	0.00454	CcSEcCtD
Sumatriptan—Photosensitivity—Lisinopril—dilated cardiomyopathy	0.00112	0.00448	CcSEcCtD
Sumatriptan—Pancreatitis—Furosemide—dilated cardiomyopathy	0.00112	0.00444	CcSEcCtD
Sumatriptan—Gastroenteritis—Lisinopril—dilated cardiomyopathy	0.00111	0.00443	CcSEcCtD
Sumatriptan—Eczema—Lisinopril—dilated cardiomyopathy	0.0011	0.00437	CcSEcCtD
Sumatriptan—Haemolytic anaemia—Lisinopril—dilated cardiomyopathy	0.00109	0.00435	CcSEcCtD
Sumatriptan—Renal failure acute—Lisinopril—dilated cardiomyopathy	0.00107	0.00426	CcSEcCtD
Sumatriptan—Somnolence—Spironolactone—dilated cardiomyopathy	0.00106	0.00421	CcSEcCtD
Sumatriptan—Pollakiuria—Furosemide—dilated cardiomyopathy	0.00105	0.00418	CcSEcCtD
Sumatriptan—Atrial fibrillation—Lisinopril—dilated cardiomyopathy	0.00104	0.00415	CcSEcCtD
Sumatriptan—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.00104	0.00413	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00103	0.00409	CcSEcCtD
Sumatriptan—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.00103	0.00408	CcSEcCtD
Sumatriptan—Anaphylactoid reaction—Lisinopril—dilated cardiomyopathy	0.00102	0.00406	CcSEcCtD
Sumatriptan—Arthritis—Lisinopril—dilated cardiomyopathy	0.00102	0.00404	CcSEcCtD
Sumatriptan—Drowsiness—Furosemide—dilated cardiomyopathy	0.00101	0.00404	CcSEcCtD
Sumatriptan—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	0.00101	0.00403	CcSEcCtD
Sumatriptan—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.00101	0.00401	CcSEcCtD
Sumatriptan—Diplopia—Lisinopril—dilated cardiomyopathy	0.000988	0.00393	CcSEcCtD
Sumatriptan—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.000988	0.00393	CcSEcCtD
Sumatriptan—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00098	0.0039	CcSEcCtD
Sumatriptan—Sweating—Furosemide—dilated cardiomyopathy	0.000973	0.00387	CcSEcCtD
Sumatriptan—Urticaria—Spironolactone—dilated cardiomyopathy	0.000945	0.00376	CcSEcCtD
Sumatriptan—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00094	0.00374	CcSEcCtD
Sumatriptan—Dehydration—Lisinopril—dilated cardiomyopathy	0.000919	0.00366	CcSEcCtD
Sumatriptan—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.000889	0.00354	CcSEcCtD
Sumatriptan—Visual impairment—Furosemide—dilated cardiomyopathy	0.000878	0.00349	CcSEcCtD
Sumatriptan—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.000876	0.00349	CcSEcCtD
Sumatriptan—Gastritis—Lisinopril—dilated cardiomyopathy	0.000874	0.00348	CcSEcCtD
Sumatriptan—Asthma—Lisinopril—dilated cardiomyopathy	0.000854	0.0034	CcSEcCtD
Sumatriptan—Influenza—Lisinopril—dilated cardiomyopathy	0.000854	0.0034	CcSEcCtD
Sumatriptan—Eye disorder—Furosemide—dilated cardiomyopathy	0.000851	0.00339	CcSEcCtD
Sumatriptan—Tinnitus—Furosemide—dilated cardiomyopathy	0.000849	0.00338	CcSEcCtD
Sumatriptan—Pruritus—Spironolactone—dilated cardiomyopathy	0.000841	0.00335	CcSEcCtD
Sumatriptan—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.00084	0.00334	CcSEcCtD
Sumatriptan—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.000837	0.00333	CcSEcCtD
Sumatriptan—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.000832	0.00331	CcSEcCtD
Sumatriptan—Angiopathy—Furosemide—dilated cardiomyopathy	0.000826	0.00329	CcSEcCtD
Sumatriptan—Immune system disorder—Furosemide—dilated cardiomyopathy	0.000823	0.00327	CcSEcCtD
Sumatriptan—Bronchitis—Lisinopril—dilated cardiomyopathy	0.000821	0.00327	CcSEcCtD
Sumatriptan—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000814	0.00324	CcSEcCtD
Sumatriptan—Arrhythmia—Furosemide—dilated cardiomyopathy	0.000814	0.00324	CcSEcCtD
Sumatriptan—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.000811	0.00323	CcSEcCtD
Sumatriptan—Dysuria—Lisinopril—dilated cardiomyopathy	0.000798	0.00318	CcSEcCtD
Sumatriptan—Erythema—Furosemide—dilated cardiomyopathy	0.000793	0.00315	CcSEcCtD
Sumatriptan—Dizziness—Spironolactone—dilated cardiomyopathy	0.000786	0.00313	CcSEcCtD
Sumatriptan—Flatulence—Furosemide—dilated cardiomyopathy	0.000781	0.00311	CcSEcCtD
Sumatriptan—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.000779	0.0031	CcSEcCtD
Sumatriptan—Weight increased—Lisinopril—dilated cardiomyopathy	0.000777	0.00309	CcSEcCtD
Sumatriptan—Dysgeusia—Furosemide—dilated cardiomyopathy	0.000776	0.00309	CcSEcCtD
Sumatriptan—Weight decreased—Lisinopril—dilated cardiomyopathy	0.000772	0.00307	CcSEcCtD
Sumatriptan—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.00077	0.00306	CcSEcCtD
Sumatriptan—Muscle spasms—Furosemide—dilated cardiomyopathy	0.000762	0.00303	CcSEcCtD
Sumatriptan—Depression—Lisinopril—dilated cardiomyopathy	0.000759	0.00302	CcSEcCtD
Sumatriptan—Vomiting—Spironolactone—dilated cardiomyopathy	0.000756	0.00301	CcSEcCtD
Sumatriptan—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.00075	0.00299	CcSEcCtD
Sumatriptan—Rash—Spironolactone—dilated cardiomyopathy	0.00075	0.00298	CcSEcCtD
Sumatriptan—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000749	0.00298	CcSEcCtD
Sumatriptan—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.000746	0.00297	CcSEcCtD
Sumatriptan—Headache—Spironolactone—dilated cardiomyopathy	0.000745	0.00296	CcSEcCtD
Sumatriptan—Anaemia—Furosemide—dilated cardiomyopathy	0.000733	0.00292	CcSEcCtD
Sumatriptan—Sweating—Lisinopril—dilated cardiomyopathy	0.00073	0.0029	CcSEcCtD
Sumatriptan—Agitation—Furosemide—dilated cardiomyopathy	0.000729	0.0029	CcSEcCtD
Sumatriptan—Haematuria—Lisinopril—dilated cardiomyopathy	0.000726	0.00289	CcSEcCtD
Sumatriptan—Epistaxis—Lisinopril—dilated cardiomyopathy	0.000718	0.00286	CcSEcCtD
Sumatriptan—Sinusitis—Lisinopril—dilated cardiomyopathy	0.000714	0.00284	CcSEcCtD
Sumatriptan—Vertigo—Furosemide—dilated cardiomyopathy	0.000712	0.00283	CcSEcCtD
Sumatriptan—Nausea—Spironolactone—dilated cardiomyopathy	0.000706	0.00281	CcSEcCtD
Sumatriptan—Bradycardia—Lisinopril—dilated cardiomyopathy	0.000696	0.00277	CcSEcCtD
Sumatriptan—Hallucination—Lisinopril—dilated cardiomyopathy	0.00068	0.00271	CcSEcCtD
Sumatriptan—Dry mouth—Furosemide—dilated cardiomyopathy	0.00066	0.00263	CcSEcCtD
Sumatriptan—Confusional state—Furosemide—dilated cardiomyopathy	0.000652	0.0026	CcSEcCtD
Sumatriptan—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.000647	0.00257	CcSEcCtD
Sumatriptan—Tinnitus—Lisinopril—dilated cardiomyopathy	0.000637	0.00254	CcSEcCtD
Sumatriptan—Shock—Furosemide—dilated cardiomyopathy	0.000637	0.00253	CcSEcCtD
Sumatriptan—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.000635	0.00252	CcSEcCtD
Sumatriptan—Flushing—Lisinopril—dilated cardiomyopathy	0.000634	0.00252	CcSEcCtD
Sumatriptan—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.000634	0.00252	CcSEcCtD
Sumatriptan—Skin disorder—Furosemide—dilated cardiomyopathy	0.000629	0.0025	CcSEcCtD
Sumatriptan—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.000626	0.00249	CcSEcCtD
Sumatriptan—Angiopathy—Lisinopril—dilated cardiomyopathy	0.00062	0.00247	CcSEcCtD
Sumatriptan—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.000616	0.00245	CcSEcCtD
Sumatriptan—Chills—Lisinopril—dilated cardiomyopathy	0.000613	0.00244	CcSEcCtD
Sumatriptan—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.00061	0.00243	CcSEcCtD
Sumatriptan—Hypotension—Furosemide—dilated cardiomyopathy	0.000605	0.00241	CcSEcCtD
Sumatriptan—Erythema—Lisinopril—dilated cardiomyopathy	0.000595	0.00237	CcSEcCtD
Sumatriptan—Flatulence—Lisinopril—dilated cardiomyopathy	0.000586	0.00233	CcSEcCtD
Sumatriptan—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.000583	0.00232	CcSEcCtD
Sumatriptan—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000581	0.00231	CcSEcCtD
Sumatriptan—Back pain—Lisinopril—dilated cardiomyopathy	0.000575	0.00229	CcSEcCtD
Sumatriptan—Somnolence—Furosemide—dilated cardiomyopathy	0.000575	0.00229	CcSEcCtD
Sumatriptan—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.000572	0.00228	CcSEcCtD
Sumatriptan—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000562	0.00224	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000559	0.00222	CcSEcCtD
Sumatriptan—Fatigue—Furosemide—dilated cardiomyopathy	0.000558	0.00222	CcSEcCtD
Sumatriptan—Tremor—Lisinopril—dilated cardiomyopathy	0.000557	0.00222	CcSEcCtD
Sumatriptan—Constipation—Furosemide—dilated cardiomyopathy	0.000553	0.0022	CcSEcCtD
Sumatriptan—Pain—Furosemide—dilated cardiomyopathy	0.000553	0.0022	CcSEcCtD
Sumatriptan—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.000552	0.0022	CcSEcCtD
Sumatriptan—Anaemia—Lisinopril—dilated cardiomyopathy	0.00055	0.00219	CcSEcCtD
Sumatriptan—Angioedema—Lisinopril—dilated cardiomyopathy	0.000544	0.00216	CcSEcCtD
Sumatriptan—Malaise—Lisinopril—dilated cardiomyopathy	0.000536	0.00213	CcSEcCtD
Sumatriptan—Vertigo—Lisinopril—dilated cardiomyopathy	0.000534	0.00213	CcSEcCtD
Sumatriptan—Syncope—Lisinopril—dilated cardiomyopathy	0.000533	0.00212	CcSEcCtD
Sumatriptan—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000533	0.00212	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000529	0.00211	CcSEcCtD
Sumatriptan—Palpitations—Lisinopril—dilated cardiomyopathy	0.000526	0.00209	CcSEcCtD
Sumatriptan—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.000523	0.00208	CcSEcCtD
Sumatriptan—Cough—Lisinopril—dilated cardiomyopathy	0.000519	0.00207	CcSEcCtD
Sumatriptan—Urticaria—Furosemide—dilated cardiomyopathy	0.000514	0.00205	CcSEcCtD
Sumatriptan—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000512	0.00204	CcSEcCtD
Sumatriptan—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000512	0.00204	CcSEcCtD
Sumatriptan—Arthralgia—Lisinopril—dilated cardiomyopathy	0.000506	0.00202	CcSEcCtD
Sumatriptan—Chest pain—Lisinopril—dilated cardiomyopathy	0.000506	0.00202	CcSEcCtD
Sumatriptan—Myalgia—Lisinopril—dilated cardiomyopathy	0.000506	0.00202	CcSEcCtD
Sumatriptan—Anxiety—Lisinopril—dilated cardiomyopathy	0.000505	0.00201	CcSEcCtD
Sumatriptan—Discomfort—Lisinopril—dilated cardiomyopathy	0.0005	0.00199	CcSEcCtD
Sumatriptan—Dry mouth—Lisinopril—dilated cardiomyopathy	0.000495	0.00197	CcSEcCtD
Sumatriptan—Confusional state—Lisinopril—dilated cardiomyopathy	0.00049	0.00195	CcSEcCtD
Sumatriptan—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.000485	0.00193	CcSEcCtD
Sumatriptan—Oedema—Lisinopril—dilated cardiomyopathy	0.000485	0.00193	CcSEcCtD
Sumatriptan—Infection—Lisinopril—dilated cardiomyopathy	0.000482	0.00192	CcSEcCtD
Sumatriptan—Shock—Lisinopril—dilated cardiomyopathy	0.000478	0.0019	CcSEcCtD
Sumatriptan—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000477	0.0019	CcSEcCtD
Sumatriptan—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000475	0.00189	CcSEcCtD
Sumatriptan—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000474	0.00189	CcSEcCtD
Sumatriptan—Skin disorder—Lisinopril—dilated cardiomyopathy	0.000472	0.00188	CcSEcCtD
Sumatriptan—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000469	0.00187	CcSEcCtD
Sumatriptan—Asthenia—Furosemide—dilated cardiomyopathy	0.000464	0.00185	CcSEcCtD
Sumatriptan—Pruritus—Furosemide—dilated cardiomyopathy	0.000458	0.00182	CcSEcCtD
Sumatriptan—Hypotension—Lisinopril—dilated cardiomyopathy	0.000454	0.00181	CcSEcCtD
Sumatriptan—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000443	0.00176	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000442	0.00176	CcSEcCtD
Sumatriptan—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000436	0.00173	CcSEcCtD
Sumatriptan—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000433	0.00172	CcSEcCtD
Sumatriptan—Somnolence—Lisinopril—dilated cardiomyopathy	0.000432	0.00172	CcSEcCtD
Sumatriptan—Dizziness—Furosemide—dilated cardiomyopathy	0.000428	0.0017	CcSEcCtD
Sumatriptan—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000422	0.00168	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000419	0.00167	CcSEcCtD
Sumatriptan—Fatigue—Lisinopril—dilated cardiomyopathy	0.000419	0.00167	CcSEcCtD
Sumatriptan—Pain—Lisinopril—dilated cardiomyopathy	0.000415	0.00165	CcSEcCtD
Sumatriptan—Constipation—Lisinopril—dilated cardiomyopathy	0.000415	0.00165	CcSEcCtD
Sumatriptan—Vomiting—Furosemide—dilated cardiomyopathy	0.000411	0.00164	CcSEcCtD
Sumatriptan—Rash—Furosemide—dilated cardiomyopathy	0.000408	0.00162	CcSEcCtD
Sumatriptan—Dermatitis—Furosemide—dilated cardiomyopathy	0.000408	0.00162	CcSEcCtD
Sumatriptan—Headache—Furosemide—dilated cardiomyopathy	0.000405	0.00161	CcSEcCtD
Sumatriptan—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.0004	0.00159	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000397	0.00158	CcSEcCtD
Sumatriptan—Urticaria—Lisinopril—dilated cardiomyopathy	0.000386	0.00153	CcSEcCtD
Sumatriptan—Nausea—Furosemide—dilated cardiomyopathy	0.000384	0.00153	CcSEcCtD
Sumatriptan—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000384	0.00153	CcSEcCtD
Sumatriptan—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000384	0.00153	CcSEcCtD
Sumatriptan—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000358	0.00142	CcSEcCtD
Sumatriptan—Asthenia—Lisinopril—dilated cardiomyopathy	0.000348	0.00139	CcSEcCtD
Sumatriptan—Pruritus—Lisinopril—dilated cardiomyopathy	0.000343	0.00137	CcSEcCtD
Sumatriptan—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000332	0.00132	CcSEcCtD
Sumatriptan—Dizziness—Lisinopril—dilated cardiomyopathy	0.000321	0.00128	CcSEcCtD
Sumatriptan—Vomiting—Lisinopril—dilated cardiomyopathy	0.000309	0.00123	CcSEcCtD
Sumatriptan—Rash—Lisinopril—dilated cardiomyopathy	0.000306	0.00122	CcSEcCtD
Sumatriptan—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000306	0.00122	CcSEcCtD
Sumatriptan—Headache—Lisinopril—dilated cardiomyopathy	0.000304	0.00121	CcSEcCtD
Sumatriptan—Nausea—Lisinopril—dilated cardiomyopathy	0.000288	0.00115	CcSEcCtD
Sumatriptan—HTR1D—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000164	0.00186	CbGpPWpGaD
Sumatriptan—HTR1D—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000162	0.00185	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000161	0.00183	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000161	0.00183	CbGpPWpGaD
Sumatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00016	0.00182	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00016	0.00182	CbGpPWpGaD
Sumatriptan—HTR1A—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00016	0.00182	CbGpPWpGaD
Sumatriptan—HTR1B—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000159	0.00181	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—TAZ—dilated cardiomyopathy	0.000157	0.00178	CbGpPWpGaD
Sumatriptan—DRD2—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000156	0.00178	CbGpPWpGaD
Sumatriptan—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000156	0.00178	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—ANKRD1—dilated cardiomyopathy	0.000154	0.00176	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000154	0.00175	CbGpPWpGaD
Sumatriptan—HTR1A—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000152	0.00172	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000149	0.0017	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000146	0.00166	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000146	0.00166	CbGpPWpGaD
Sumatriptan—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000145	0.00165	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—TAZ—dilated cardiomyopathy	0.000145	0.00165	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000145	0.00165	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—ANKRD1—dilated cardiomyopathy	0.000143	0.00162	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—SDHA—dilated cardiomyopathy	0.000142	0.00161	CbGpPWpGaD
Sumatriptan—DRD2—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000141	0.0016	CbGpPWpGaD
Sumatriptan—DRD2—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00014	0.0016	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00014	0.00159	CbGpPWpGaD
Sumatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000137	0.00156	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000137	0.00156	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000136	0.00154	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000136	0.00154	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000136	0.00154	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—TAZ—dilated cardiomyopathy	0.000134	0.00152	CbGpPWpGaD
Sumatriptan—DRD2—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000133	0.00151	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000133	0.00151	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—ANKRD1—dilated cardiomyopathy	0.000132	0.0015	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—SDHA—dilated cardiomyopathy	0.000131	0.00149	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000131	0.00149	CbGpPWpGaD
Sumatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00013	0.00148	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00013	0.00148	CbGpPWpGaD
Sumatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000129	0.00147	CbGpPWpGaD
Sumatriptan—DRD2—Circadian rythm related genes—FAS—dilated cardiomyopathy	0.000129	0.00146	CbGpPWpGaD
Sumatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000126	0.00144	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000126	0.00143	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—TAZ—dilated cardiomyopathy	0.000124	0.00141	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000123	0.00141	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000122	0.00139	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—SDHA—dilated cardiomyopathy	0.000121	0.00138	CbGpPWpGaD
Sumatriptan—HTR1A—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000121	0.00138	CbGpPWpGaD
Sumatriptan—DRD2—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00012	0.00137	CbGpPWpGaD
Sumatriptan—DRD2—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000119	0.00135	CbGpPWpGaD
Sumatriptan—DRD2—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000119	0.00135	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000117	0.00133	CbGpPWpGaD
Sumatriptan—DRD2—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000114	0.0013	CbGpPWpGaD
Sumatriptan—MAOA—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000113	0.00128	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—SDHA—dilated cardiomyopathy	0.000112	0.00128	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000112	0.00128	CbGpPWpGaD
Sumatriptan—DRD2—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000111	0.00126	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000109	0.00124	CbGpPWpGaD
Sumatriptan—DRD2—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000107	0.00122	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000106	0.00121	CbGpPWpGaD
Sumatriptan—DRD2—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000106	0.00121	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000106	0.0012	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000106	0.0012	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000104	0.00119	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000103	0.00117	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000103	0.00117	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000101	0.00114	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000101	0.00114	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR ligand binding—ADRB2—dilated cardiomyopathy	9.89e-05	0.00113	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR ligand binding—AGT—dilated cardiomyopathy	9.83e-05	0.00112	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	9.82e-05	0.00112	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—PSEN2—dilated cardiomyopathy	9.7e-05	0.0011	CbGpPWpGaD
Sumatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	9.63e-05	0.0011	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR ligand binding—AGT—dilated cardiomyopathy	9.63e-05	0.0011	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	9.55e-05	0.00109	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	9.35e-05	0.00106	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—AGTR2—dilated cardiomyopathy	9.33e-05	0.00106	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—CXCL2—dilated cardiomyopathy	9.33e-05	0.00106	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	9.25e-05	0.00105	CbGpPWpGaD
Sumatriptan—DRD2—GPCR ligand binding—AGTR1—dilated cardiomyopathy	9.15e-05	0.00104	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—CXCL2—dilated cardiomyopathy	9.13e-05	0.00104	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—AGTR2—dilated cardiomyopathy	9.13e-05	0.00104	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR downstream signaling—RAC1—dilated cardiomyopathy	9.09e-05	0.00103	CbGpPWpGaD
Sumatriptan—HTR3A—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	9.06e-05	0.00103	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	9.05e-05	0.00103	CbGpPWpGaD
Sumatriptan—MAOA—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	8.96e-05	0.00102	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR downstream signaling—AGT—dilated cardiomyopathy	8.69e-05	0.000989	CbGpPWpGaD
Sumatriptan—DRD2—GPCR ligand binding—ADRB2—dilated cardiomyopathy	8.68e-05	0.000988	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—CXCR3—dilated cardiomyopathy	8.67e-05	0.000987	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	8.64e-05	0.000984	CbGpPWpGaD
Sumatriptan—MAOA—Neuronal System—RAF1—dilated cardiomyopathy	8.62e-05	0.000981	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—CXCL2—dilated cardiomyopathy	8.61e-05	0.00098	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—AGTR2—dilated cardiomyopathy	8.61e-05	0.00098	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	8.6e-05	0.000979	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—CXCR3—dilated cardiomyopathy	8.49e-05	0.000966	CbGpPWpGaD
Sumatriptan—DRD2—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	8.46e-05	0.000962	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	8.42e-05	0.000958	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—ADRB1—dilated cardiomyopathy	8.4e-05	0.000955	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	8.3e-05	0.000944	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—RAC1—dilated cardiomyopathy	8.26e-05	0.00094	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—ADRB1—dilated cardiomyopathy	8.22e-05	0.000936	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	8.13e-05	0.000926	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—CXCR3—dilated cardiomyopathy	8.01e-05	0.000911	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	7.9e-05	0.000899	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—AGT—dilated cardiomyopathy	7.89e-05	0.000898	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—ADRB1—dilated cardiomyopathy	7.76e-05	0.000883	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	7.73e-05	0.00088	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	7.66e-05	0.000872	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	7.66e-05	0.000872	CbGpPWpGaD
Sumatriptan—HTR1A—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	7.62e-05	0.000867	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	7.58e-05	0.000863	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	7.49e-05	0.000852	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	7.39e-05	0.000841	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	7.34e-05	0.000835	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR ligand binding—AGT—dilated cardiomyopathy	7.33e-05	0.000835	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	7.2e-05	0.000819	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—AGTR1—dilated cardiomyopathy	7.17e-05	0.000816	CbGpPWpGaD
Sumatriptan—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	7.14e-05	0.000812	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	7.14e-05	0.000812	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	7.12e-05	0.00081	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—AGTR1—dilated cardiomyopathy	7.02e-05	0.000799	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	6.96e-05	0.000792	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	6.96e-05	0.000792	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	6.9e-05	0.000785	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—ADRB2—dilated cardiomyopathy	6.8e-05	0.000774	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	6.73e-05	0.000765	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	6.73e-05	0.000765	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	6.71e-05	0.000763	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—ADRB2—dilated cardiomyopathy	6.66e-05	0.000758	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—AGTR1—dilated cardiomyopathy	6.62e-05	0.000754	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	6.48e-05	0.000738	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	6.47e-05	0.000736	CbGpPWpGaD
Sumatriptan—DRD2—GPCR ligand binding—AGT—dilated cardiomyopathy	6.44e-05	0.000733	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—ADRB2—dilated cardiomyopathy	6.28e-05	0.000715	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	6.26e-05	0.000713	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	6.25e-05	0.000711	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—PSEN2—dilated cardiomyopathy	6.2e-05	0.000706	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	6.11e-05	0.000695	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	6.11e-05	0.000695	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—PSEN2—dilated cardiomyopathy	6.08e-05	0.000691	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	6.07e-05	0.00069	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	6.06e-05	0.000689	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	5.89e-05	0.00067	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—RAC1—dilated cardiomyopathy	5.82e-05	0.000662	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—RAC1—dilated cardiomyopathy	5.69e-05	0.000648	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	5.68e-05	0.000646	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	5.59e-05	0.000636	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—AGT—dilated cardiomyopathy	5.56e-05	0.000632	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CXCL2—dilated cardiomyopathy	5.51e-05	0.000627	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—AGTR2—dilated cardiomyopathy	5.51e-05	0.000627	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	5.5e-05	0.000626	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—RAF1—dilated cardiomyopathy	5.48e-05	0.000623	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—AGT—dilated cardiomyopathy	5.44e-05	0.000619	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	5.4e-05	0.000614	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—AGTR2—dilated cardiomyopathy	5.39e-05	0.000614	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CXCL2—dilated cardiomyopathy	5.39e-05	0.000614	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	5.39e-05	0.000614	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	5.35e-05	0.000609	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—RAC1—dilated cardiomyopathy	5.28e-05	0.000601	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	5.17e-05	0.000588	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—RAC1—dilated cardiomyopathy	5.17e-05	0.000588	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CXCR3—dilated cardiomyopathy	5.12e-05	0.000583	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	5.07e-05	0.000577	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—AGT—dilated cardiomyopathy	5.05e-05	0.000574	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CXCR3—dilated cardiomyopathy	5.01e-05	0.000571	CbGpPWpGaD
Sumatriptan—SLCO1A2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	5e-05	0.000569	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—ADRB1—dilated cardiomyopathy	4.96e-05	0.000564	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—AGT—dilated cardiomyopathy	4.94e-05	0.000562	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	4.91e-05	0.000558	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—RAC1—dilated cardiomyopathy	4.88e-05	0.000555	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—ADRB1—dilated cardiomyopathy	4.86e-05	0.000553	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	4.7e-05	0.000534	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—AGT—dilated cardiomyopathy	4.66e-05	0.00053	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PSEN2—dilated cardiomyopathy	4.63e-05	0.000527	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—ADRB2—dilated cardiomyopathy	4.46e-05	0.000507	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	4.34e-05	0.000494	CbGpPWpGaD
Sumatriptan—SLCO1B1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	4.28e-05	0.000487	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—AGTR1—dilated cardiomyopathy	4.24e-05	0.000482	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—AGTR1—dilated cardiomyopathy	4.15e-05	0.000472	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—AGT—dilated cardiomyopathy	4.14e-05	0.000472	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CXCL2—dilated cardiomyopathy	4.11e-05	0.000468	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—AGTR2—dilated cardiomyopathy	4.11e-05	0.000468	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PSEN2—dilated cardiomyopathy	4.06e-05	0.000462	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—ADRB2—dilated cardiomyopathy	4.02e-05	0.000457	CbGpPWpGaD
Sumatriptan—ABCG2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	3.96e-05	0.000451	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—RAC1—dilated cardiomyopathy	3.94e-05	0.000448	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.94e-05	0.000448	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—GPX1—dilated cardiomyopathy	3.85e-05	0.000438	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CXCR3—dilated cardiomyopathy	3.82e-05	0.000435	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	3.81e-05	0.000433	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—AGT—dilated cardiomyopathy	3.76e-05	0.000428	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.76e-05	0.000427	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—CD36—dilated cardiomyopathy	3.75e-05	0.000427	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—ADRB1—dilated cardiomyopathy	3.7e-05	0.000421	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	3.7e-05	0.000421	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—AGT—dilated cardiomyopathy	3.64e-05	0.000414	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—AGTR2—dilated cardiomyopathy	3.61e-05	0.000411	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CXCL2—dilated cardiomyopathy	3.61e-05	0.000411	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—GPX1—dilated cardiomyopathy	3.57e-05	0.000406	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	3.52e-05	0.000401	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—RAF1—dilated cardiomyopathy	3.5e-05	0.000398	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—CD36—dilated cardiomyopathy	3.47e-05	0.000395	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—RAC1—dilated cardiomyopathy	3.46e-05	0.000394	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.45e-05	0.000393	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—RAF1—dilated cardiomyopathy	3.43e-05	0.00039	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.38e-05	0.000385	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—AGT—dilated cardiomyopathy	3.38e-05	0.000384	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CXCR3—dilated cardiomyopathy	3.35e-05	0.000382	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—AGT—dilated cardiomyopathy	3.3e-05	0.000376	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—GPX1—dilated cardiomyopathy	3.29e-05	0.000375	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—ADRB1—dilated cardiomyopathy	3.25e-05	0.00037	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—RAF1—dilated cardiomyopathy	3.23e-05	0.000368	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—CD36—dilated cardiomyopathy	3.21e-05	0.000365	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.16e-05	0.00036	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—AGT—dilated cardiomyopathy	3.13e-05	0.000356	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—RAC1—dilated cardiomyopathy	3.12e-05	0.000355	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—RAC1—dilated cardiomyopathy	3.05e-05	0.000348	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—GPX1—dilated cardiomyopathy	3.05e-05	0.000347	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	3e-05	0.000341	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—AGT—dilated cardiomyopathy	2.98e-05	0.000339	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—CD36—dilated cardiomyopathy	2.97e-05	0.000338	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—AGT—dilated cardiomyopathy	2.92e-05	0.000332	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—AGT—dilated cardiomyopathy	2.89e-05	0.000328	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.77e-05	0.000316	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—AGT—dilated cardiomyopathy	2.67e-05	0.000304	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.63e-05	0.000299	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.61e-05	0.000297	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.58e-05	0.000293	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.4e-05	0.000273	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.35e-05	0.000268	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—RAC1—dilated cardiomyopathy	2.33e-05	0.000265	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.29e-05	0.000261	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.26e-05	0.000257	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—AGT—dilated cardiomyopathy	2.22e-05	0.000253	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—EGFR—dilated cardiomyopathy	2.22e-05	0.000252	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.14e-05	0.000244	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—RAF1—dilated cardiomyopathy	2.07e-05	0.000235	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—RAC1—dilated cardiomyopathy	2.04e-05	0.000232	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—RAF1—dilated cardiomyopathy	2.03e-05	0.00023	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—AGT—dilated cardiomyopathy	1.95e-05	0.000222	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.79e-05	0.000204	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	1.65e-05	0.000188	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CD36—dilated cardiomyopathy	1.61e-05	0.000183	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.57e-05	0.000179	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—RAF1—dilated cardiomyopathy	1.54e-05	0.000176	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—AGT—dilated cardiomyopathy	1.45e-05	0.000164	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—EGFR—dilated cardiomyopathy	1.42e-05	0.000161	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—EGFR—dilated cardiomyopathy	1.39e-05	0.000158	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—RAF1—dilated cardiomyopathy	1.35e-05	0.000154	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—EGFR—dilated cardiomyopathy	1.06e-05	0.00012	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—EGFR—dilated cardiomyopathy	9.29e-06	0.000106	CbGpPWpGaD
